Overview

mTOR as Mediator of Insulin Sensitivity Study

Status:
Recruiting

Trial end date:
2029-06-01

Target enrollment:

Participant gender:

Summary

The study investigates the role of mTOR in mediating enhancement of muscle insulin sensitivity following a single bout of exercise. This will be investigated in young healthy male subjects by administering the pharmacological mTOR inhibitor Rapamycin in a crossover blinded experimental setup known to enhance muscle insulin sensitivity following one-legged knee-extensor exercise.

Phase:

N/A

Details

Lead Sponsor:

University of Copenhagen

Collaborator:

Danish Diabetes Academy

Treatments:

Sirolimus